Cargando…
Overcoming nonstructural protein 15-nidoviral uridylate-specific endoribonuclease (nsp15/NendoU) activity of SARS-CoV-2
COVID-19 has become the gravest global public health crisis since the Spanish Flu of 1918. Combination antiviral therapy with repurposed broad-spectrum antiviral agents holds a highly promising immediate treatment strategy, especially given uncertainties of vaccine efficacy and developmental timelin...
Autor principal: | Senanayake, Suranga L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Newlands Press Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255426/ http://dx.doi.org/10.4155/fdd-2020-0012 |
Ejemplares similares
-
Crystal structure of Nsp15 endoribonuclease NendoU from SARS‐CoV‐2
por: Kim, Youngchang, et al.
Publicado: (2020) -
Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2
por: Kim, Youngchang, et al.
Publicado: (2021) -
Room-temperature structural studies of SARS-CoV-2 protein NendoU with an X-ray free-electron laser
por: Jernigan, Rebecca J., et al.
Publicado: (2023) -
Reversible and irreversible inhibitors of coronavirus Nsp15 endoribonuclease
por: Chen, Jerry, et al.
Publicado: (2023) -
Cryo-EM Structures of the SARS-CoV-2 Endoribonuclease Nsp15
por: Pillon, Monica C., et al.
Publicado: (2020)